Specific solvents may increase risk of Parkinson's disease

Specific solvents may increase risk of parkinson's disease
Exposure to specific solvents is associated with an increased risk of Parkinson's disease, according to a study published in the June issue of the Annals of Neurology.

(HealthDay) -- Exposure to specific solvents is associated with an increased risk of Parkinson's disease, according to a study published in the June issue of the Annals of Neurology.

In effort to assess whether exposure to specific solvents is associated with Parkinson's disease risk, Samuel M. Goldman, M.D., M.P.H., of The Parkinson's Institute in Sunnyvale, Calif., and colleagues conducted a discordant twin pair design study involving 99 . Participants were interviewed using detailed job task-specific questionnaires regarding lifetime occupations and hobbies.

The researchers found that exposure to trichloroethylene (TCE) correlated with a significantly increased risk of Parkinson's disease (odds ratio [OR], 6.1; P = 0.034). There was a trend toward significance for exposure to perchloroethylene (PERC; OR, 10.5; P = 0.053) and (CCl4; OR, 2.3; P = 0.088).

"Although the present work focused on , solvents are ubiquitous in the environment, and this is particularly true for those implicated in this study -- TCE, PERC, and CCl4," the authors write. "Our findings require replication in other populations with well-characterized exposures, but the potential public health implications are considerable."

Several authors disclosed financial ties to the pharmaceutical, medical device, and health care industries.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Can exercise help people with Parkinson's disease?

Dec 31, 2014

Exercise may help people with Parkinson's disease improve their balance, ability to move around and quality of life, even if it does not reduce their risk of falling, according to a new study published in ...

Tackling Parkinson's with targeted therapeutic vaccines

Dec 24, 2014

Clinical trials are about to begin on a new Parkinson's disease vaccine that could offer patients significant improvements over current treatments. The vaccine, developed through the FP7-funded SYMPATH project, ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.